<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Nathan Fishkin | Kriegstein Lab</title>
    <link>https://www.kriegstein-lab.com/author/nathan-fishkin/</link>
      <atom:link href="https://www.kriegstein-lab.com/author/nathan-fishkin/index.xml" rel="self" type="application/rss+xml" />
    <description>Nathan Fishkin</description>
    <generator>Hugo Blox Builder (https://hugoblox.com)</generator><language>en-us</language><lastBuildDate>Mon, 01 Sep 2003 00:00:00 +0000</lastBuildDate>
    <image>
      <url>https://www.kriegstein-lab.com/media/icon_hu_48c5201f68d3f81e.png</url>
      <title>Nathan Fishkin</title>
      <link>https://www.kriegstein-lab.com/author/nathan-fishkin/</link>
    </image>
    
    <item>
      <title>Terpene trilactones from Ginkgo biloba are antagonists of cortical glycine and GABA(A) receptors</title>
      <link>https://www.kriegstein-lab.com/publication/ivic-2003-fv/</link>
      <pubDate>Mon, 01 Sep 2003 00:00:00 +0000</pubDate>
      <guid>https://www.kriegstein-lab.com/publication/ivic-2003-fv/</guid>
      <description></description>
    </item>
    
  </channel>
</rss>
